Follow the 프롬바이오 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 프롬바이오 has published 32 insider filings. The latest transaction was reported on 2 July 2026 (Purchase). Among the most active insiders: 심태진. Every trade is openly available.
30
Insider Decl.
n/a
Thresholds
n/a
17 ops.
Buy Volume
n/a
n/a
Sell Volume
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.